Luminare
PrivateLast Round
Accelerator
Mar 29, 2024
Total Funding Raised
$597,500
Company Overview
Luminare operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was an Accelerator round in March 2024.
Luminare is a healthcare technology company that provides software-driven workflow optimization and clinical decision support tools, including its flagship sepsis management platform, Sagitta.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Healthcare Analytics, Revenue Cycle
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminare Comparables
Compare Luminare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucent Health | 86% | |
| Allied Benefit Systems | 82% | |
| GuideWell | 82% |
For institutional investors. Book with your work email.
Luminare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 29, 2024 | ||||
| Accelerator | Aug 23, 2022 | ||||
| Accelerator | Jun 7, 2018 | ||||
| Seed | Jun 14, 2017 |
For institutional investors. Book with your work email.
Luminare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Carnrite Ventures | Seed |
| RedHouse Associates | Seed |
| Cedars-Sinai Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 29, 2024
Completed an accelerator round of funding.
- Jun 7, 2018
Completed an Accelerator round of funding.
For institutional investors. Book with your work email.
Luminare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luminare's valuation, stock price, and market status.
Is Luminare a public or private company?
Luminare is a private company.
What is the current stock price of Luminare?
Luminare is a private company, so its shares have no public market price. Caplight tracks Luminare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luminare worth (valuation)?
Valuation information for Luminare is not publicly available.
Can I buy Luminare stock?
Luminare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luminare's last funding round?
Luminare's most recent funding round was Accelerator on March 29, 2024.
Who are the main investors in Luminare?
Key investors in Luminare include Cedars-Sinai Accelerator.
Will Luminare IPO soon?
No public IPO plans have been announced for Luminare.
How can I track Luminare secondary market activity?
Caplight tracks bids, offers, and trades in Luminare's shares on secondary markets.